Each of these three small-cap biotech stocks surged more than 100% last week. The author of today’s article notes that “It isn’t unusual to see small-cap biotechs with nine-figure market caps continue to make further gains, but they don’t always continue rising.” So which of these three small-cap biotechs might be at the beginning of a much larger move higher? CLICK HERE.
